---All---
  • ---All---
  • Accession
  • Catalog #

AEBP1 Antibody (Center)Peptide Affinity Purified Rabbit Polyclonal Antibody (Pab)

Country
United States
Australia Austria Belgium Brazil Bulgaria Canada China Croatia Cyprus Czech Republic Denmark Estonia Finland France Germany Greece Hungary Iceland India Indonesia Ireland Israel Italy Japan Korea Latvia Lithuania Luxembourg Macedonia Malaysia Malta Netherlands Norway Pakistan Poland Portugal Romania Serbia Singapore Slovakia Slovenia Spain Sweden Switzerland Taiwan Turkey United Kingdom United States Vietnam Others
Ordering Information
Catalog # Size Availability Price  
AP10098c 0.1 mg 400 ul In Stock $ 255.00 Add to cart
AP10098c-ev20 20 ug 100 ul In Stock $ 95.00 Add to cart
  • Specification
  • Citiations : 0
  • Reviews
  • Protocols
  • Backgrounds

AEBP1 Antibody (Center) - Product info

ApplicationWB
  • Applications Legend:
  • W=Western Blotting
  • IP=Immunoprecipitation
  • IHC-P=Immunohistochemistry (Paraffin)
  • IF-IC=Immunofluorescence (Immunocytochemistry)
  • F=Flow Cytometry
Primary AccessionQ8IUX7
Other AccessionNP_001120.3
ReactivityHuman, Mouse
Concentration0.25 mg/ml
IsotypeRabbit Ig
Calculated MW130929 Da

AEBP1 Antibody (Center) - Additional info

Gene ID 165
Other Names
AEBP1; ACLP; Adipocyte enhancer-binding protein 1; Aortic carboxypeptidase-like protein
Target/Specificity
This AEBP1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 341-372 amino acids from the Central region of human AEBP1.
Dilution
WB~~1:100~500
Format
Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification.
Storage
Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Precautions
AEBP1 Antibody (Center) is for research use only and not for use in diagnostic or therapeutic procedures.

AEBP1 Antibody (Center) - Protein Information

Name AEBP1
Synonyms ACLP
Function
May positively regulate MAP-kinase activity in adipocytes, leading to enhanced adipocyte proliferation and reduced adipocyte differentiation (By similarity). May also positively regulate NF-kappa-B activity in macrophages by promoting the phosphorylation and subsequent degradation of I- kappa-B-alpha (NFKBIA), leading to enhanced macrophage inflammatory responsiveness (By similarity). Can act as a transcriptional repressor (By similarity)
Cellular Location
Isoform 1: Secreted (By similarity).
Tissue Location
Expressed in osteoblast and visceral fat.

AEBP1 Antibody (Center) - Related products

AP10098c: AEBP1 Antibody (Center)

RI10158: AEBP1 predesign siRNA

BP10098c: AEBP1 Antibody (Center) Blocking peptide

AT1062a: AEBP1 Antibody (monoclonal) (M01)

Abgent welcomes feedback from its customers.

If you have used an Abgent product and would like to share how it has performed, please click on the
"Submit Review" button and provide the requested information. Our staff will examine and post your
review and contact you if needed.

If you have any additional inquiries please email technical services at tech@abgent.com.

Thank you for your support.


Submit

Provided below are standard protocols that you may find useful for product applications.

BACKGROUND

The adipocyte enhancer binding protein 1 is a transcriptional repressor with carboxypeptidase (CP) activity. This protein binds to a regulatory sequence, adipocyte enhancer 1 (AE-1), located in the proximal promoter region of the adipose P2 (aP2) gene, which encodes the adipocyte fatty-acid binding protein. It is characterized as a member of the regulatory B-like CP family. This protein seems to be activated by a novel mechanism, whereby the direct binding of DNA enhances its protease activity. Adipocyte-enhancer binding protein 1 may play a role in differentiated vascular smooth muscle cells.

REFERENCES

Majdalawieh, A., et al. Nucl Recept Signal 8, E004 (2010) : Schissel, S.L., et al. Am. J. Pathol. 174(3):818-828(2009) Zhang, L., et al. Mol. Med. 11 (1-12), 39-47 (2005) : Layne, M.D., et al. Mol. Cell. Biol. 21(15):5256-5261(2001) Muise, A.M., et al. Biochem. J. 343 PT 2, 341-345 (1999) :